V08CA09 gadobutrol

VARIOUS CONTRAST MEDIA MAGNETIC RESONANCE IMAGING CONTRAST MEDIA Paramagnetic contrast media

非健保收載 TFDA 在效許可證 1 FDA 已核准

台灣藥品與外觀

台灣食藥署在效西藥許可證 1 張;以下列出 1 個品項。

無外觀照
蓋多維斯 1.0

資料來源:食藥署「西藥許可證」+「藥品 ATC 碼」+「藥品外觀」+「藥品仿單或外盒」開放資料。外觀照與仿單連結指向食藥署原始檔。

適應症

台灣 TFDA 核准適應症

  1. 適用於成人及所有年齡層兒童(包括足月新生兒)的全身磁振造影增強作用(MRI)、包括:(一)顱部和脊髓磁振造影(MRI)增強作用(二)乳房磁振造影(MRI)增強作用(三)腹部磁振造影(MRI)增強作用(肝臟)(四)骨盆磁振造影(MRI)增強作用(前列腺和子宮)(五)後腹腔磁振造影(MRI)增強作用(腎臟)(六)肢端和肌肉骨骼系統磁振造影(MRI)增強作用(七)血管磁振造影增強作用(CE-MRA)(八)心臟磁振造影(CardiacMRI)增強作用:針對已知或疑似患有冠狀動脈疾病(coronaryarterydisease、CAD)的成年病人、用於心臟磁振造影以評估壓力測試(stress)與休息狀態(rest)的心肌灌注、以及評估延遲顯影(lategadoliniumenhancement)。

美國 FDA 適應症(英文原文對照)

美國 FDA 核准成分 gadobutrol (商品名 Gadobutrol) · 仿單更新 2025-07-15

1 INDICATIONS AND USAGE Gadobutrol injection is a gadolinium-based contrast agent indicated for use with magnetic resonance imaging (MRI): • To detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system in adult and pediatric patients, including term neonates ( 1.1 ) • To assess the presence and extent of malignant breast disease in adult patients ( 1.2 ) • To evaluate known or suspected supra-aortic or renal artery disease in adult and pediatric patients, including term neonates ( 1.3 ) • To assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD). ( 1.4 ). 1.1 Magnetic Resonance Imaging (MRI) of the Central Nervous System (CNS) Gadobutrol injection is indicated for use with magnetic resonance imaging (MRI) in adult and pediatric patients, including term neonates to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system. 1.2 MRI of the Breast Gadobutrol injection is indicated for use with MRI in adult patients to assess the presence and extent of malignant breast disease. 1.3 Magnetic Resonance Angiography (MRA) Gadobutrol injection is indicated for use in magnetic resonance angiography (MRA) in adult and pediatric patients, including term neonates, to evaluate known or suspected supra-aortic or renal artery disease. 1.4 Cardiac MRI Gadobutrol injection is indicated for use in cardiac MRI (CMRI) to assess myocardial perfusion (stress, rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD).

資料來源:食藥署西藥許可證適應症(中文)、openFDA US SPL(英文,僅供對照)。

健保給付規定

查無健保特殊給付規定條款;本藥品依一般健保藥品支付規定給付。

實證補充

本藥品尚無實證補充整理(未來新增 Review/指引知識時補列)。


台灣藥品與適應症:食藥署西藥許可證+ATC+外觀+仿單開放資料 · FDA:openFDA US SPL · 健保給付:健保署「全民健康保險藥品給付規定」(更新日 2026-06-09)· 實證補充:人工彙整。 本頁為資訊整理,實際給付與適應症以主管機關公告為準。